Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing

Advances in Molecular Pathology – In this article, the authors discuss existing data and ongoing efforts to generate evidence in support of genotype-guided therapy approaches and reimbursement for pharmacogenomic testing.